Hayakawa J, Suzuki H, Yoshida G, Usuda Y, Numata K
Department of Anesthesia, Kanagawa Cancer Center Hospital, Yokohama.
Masui. 1990 Apr;39(4):459-64.
Arterial blood ketone body ratio (AKBR; acetoacetate/beta-hydroxybutyrate) is known as a parameter to indicate the function of the liver cells. We evaluated the effects of induced hypotension with prostaglandin E1 (PGE1) or trimetaphan (TMP) on AKBR in patients without liver disease undergoing mastectomy. Almost no change was observed in AKBR before, during and after hypotension with PGE1, but slight diminution was observed during hypotension with TMP. No hepatic dysfunction, however, developed in these patients postoperatively. These findings suggest that usual hypotension with TMP may provoke no postoperative hepatic dysfunction in patients without liver disease. For the patient who required either hypotension of long duration or hypotension with other factors affecting function of liver (surgical procedures, drugs and others), we prefer PGE1 to TMP as a hypotensive drug. We should also adopt PGE1 when cardiovascular control with hypotensive drug is necessary in patients with liver disease.
动脉血酮体比率(AKBR;乙酰乙酸/β-羟基丁酸)是一种用于指示肝细胞功能的参数。我们评估了在接受乳房切除术且无肝脏疾病的患者中,使用前列腺素E1(PGE1)或曲美芬(TMP)诱导低血压对AKBR的影响。使用PGE1诱导低血压期间及前后,AKBR几乎没有变化,但使用TMP诱导低血压期间观察到轻微下降。然而,这些患者术后均未出现肝功能障碍。这些发现表明,对于无肝脏疾病的患者,通常使用TMP诱导低血压可能不会引发术后肝功能障碍。对于需要长时间低血压或因其他影响肝脏功能的因素(手术操作、药物等)而导致低血压的患者,作为降压药物,我们更倾向于使用PGE1而非TMP。当肝病患者需要使用降压药物进行心血管控制时,我们也应选用PGE1。